CohBar, Inc. To Announce 2015 Third Quarter Financial Results and Host Conference Call for Shareholders on November 16, 2015
Menlo Park, California – November 11, 2015 – CohBar, Inc. (OTCQX: CWBR and TSX-V: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, will release its 2015 third quarter financial results on Monday, November 16, 2015, and will host a call for shareholders the same day at 2:00 p.m. (PDT).
Conference Call Information:
Date: November 16, 2015
Time: 2:00 p.m. (PDT)
Dial-in U.S. and Canada: (844) 208-1764
Dial-in International: (815) 680-6587
Conference ID# 80443662
An audio recording of the call will be available beginning 5 p.m. PDT on November 16, 2015, through 5:30 p.m. PDT on November 23, 2015. To access the recording please dial (855) 859-2056 in the U.S. and Canada or (404) 537-3406 internationally and reference Conference ID# 80443662.
CohBar (OTCQX: CWBR and TSXV: COB.U) is a leader in the research and development of mitochondria-based therapeutics, an emerging class of drugs for the treatment of diseases associated with aging. MBTs originate from the discovery of a novel group of peptides within the genome of mitochondria, the powerhouses of the cell. This groundbreaking discovery was made by our founders, world leaders in the biology of aging, metabolism and mitochondrial genomics. MBTs offer the potential to address a broad range of diseases such as type 2 diabetes, cancer, atherosclerosis and neurodegenerative disorders.
For additional company information, please visit www.cohbar.com.
Jeff Biunno, CFO
MacDougall Biomedical Communications